Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto

Details for Australian Patent Application No. 2004261582 (hide)

International Classifications

Event Publications

19 January 2006 Amendment Made

The nature of the amendment is: Amend the invention title to read Diaryl and arylheteroaryl urea derivatives as modulators of the 5-HT2A serotonin receptor useful for the prophylaxis and treatment of disorders related thereto 2004265235 Nalco Company The nature of the amendment is as shown in the statement(s) filed 15 Dec 2005

19 January 2006 PCT application entered the National Phase

PCT publication WO2005/012254 Priority application(s): WO2005/012254

12 February 2009 Application Accepted

Published as AU-B-2004261582

11 June 2009 Standard Patent Sealed

20 August 2009 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 14 Jul 2009. Address for service in Australia - FB Rice & Co Level 23 44 Market Street Sydney NSW 2000

7 January 2010 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 14 Jul 2009

28 January 2010 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 06 Jan 2010. Address for service in Australia - FB Rice & Co Level 23 44 Market Street Sydney NSW 2000

10 June 2010 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 06 Jan 2010 2006

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.